Changes in the phosphorylation state of p53 are important in increasing its half-life and potency as a transcription factor. To investigate their roles, serine residues 15 and 37 were mutated to alanines and the mutated proteins were expressed stably at low basal levels in Li-Fraumeni-derived p53-null human ®broblasts. The accumulation of p53 after DNA damage was analysed quantitatively in multiple clones. Mutation of serine 15, serine 37 or both impaired the accumulation of the protein after exposing the cells to ultraviolet radiation (50 ± 100% increase for the mutant proteins, 500% increase for wild-type p53) but not after treatment with adriamycin. The diminished accumulation of mutant p53 protein is due to a reduction of basal HDM association. Analysis of p53-dependent transcription revealed that phosphorylation of serine 15 is required to maintain basal levels of p21 mRNA. These results provide new evidence for an important function of serine 37 phosphorylation, clearly distinguish the pathways of p53 activation in response to ultraviolet radiation or DNA damage in¯icted by adriamycin, and reveal that serine 15 is crucial to support the p53-mediated basal expression of p21. Oncogene (2001) 20, 1076 ± 1084.
Introduction p53 functions as a tumor suppressor, mediating growth arrest and apoptosis in response to DNA damage or adverse environmental conditions (Ljungman, 2000; Prives and Hall, 1999; Agarwal et al., 1998) . Changes in the properties of p53 following damage are due to post-translational modi®cations. Use of phosphorylation and acetylation site-speci®c antibodies has demonstrated that serines 6, 9, 15, 20, 33, 37 , and 392 and threonine 18 are phosphorylated, serines 376 and 378 are dephosphorylated, and lysines 320 and 382 are acetylated after DNA damage, indicating that kinases, phosphatases, and acetylases participate in damage response pathways leading to p53 activation. Sakaguchi et al., 1998 Sakaguchi et al., , 2000 Shieh et al., 1997 Shieh et al., , 1999 Kapoor and Lozano, 1998; Lu et al., 1998; Waterman et al., 1998; Gu and Roeder, 1997; Siliciano et al., 1997; Takenaka et al., 1995) .
Protein kinases known to respond to cellular stress, which can phosphorylate p53 in vitro, are attractive candidates for signaling to p53 in vivo. DNA-damage responsive members of the phosphatidylinositol 3' kinase family (DNA-PK, ATM, and ATR) phosphorylate p53 in vitro (Khanna and Lavin, 1993; Lees-Miller et al., 1992; Wang and Eckhart, 1992; Carter et al., 1990) . DNA-PK, a nuclear serine-threonine kinase consisting of a catalytic subunit and a DNA-targeting subunit, phosphorylates p53 on serines 15 and 37. However, this kinase does not appear to be absolutely required for p53 to function Burma et al., 1999; Jimenez et al., 1999) . ATM phosphorylates p53 on serine 15 in vitro, and the induction and activation of p53 following ionizing radiation are delayed in ATM-de®cient cells (Banin et al., 1998; Canman et al., 1998) . ATR phosphorylates serines 15 and 37 in vitro and the expression of dominant negative ATR inhibits the phosphorylation of serine 15 after DNA damage (Tibbits et al., 1999) . These studies place ATM and ATR in the DNA damage signaling pathway upstream of p53. Furthermore, serine 20 is phosphorylated in vitro by Chk1 and Chk2, both of which are activated by ATM following DNA damage (Chehab et al., 2000; Hirao et al., 2000; Shieh et al., 2000) . JNK1, a member of the stressactivated protein kinase family, is activated following UV irradiation and phosphorylates serine 34 of murine p53, (orthologous to serines 33 and 37 of human p53); murine serine 34 and human serine 33 and 37 are also phosphorylated in vivo after irradiation with UV Milne et al., 1995) . JNK1 may play a role in regulating the turnover of p53 following UV-induced damage to DNA (Fuchs et al., 1998a,b) .
Phosphorylation of serine residues in the aminoterminal region of p53 is required to regulate its binding to the negative regulator HDM. In untreated cells, HDM inhibits the function of p53 by blocking the transactivation domain and by targeting p53 for proteosome-mediated degradation (Haupt et al., 1997; Kubbutat et al., 1997; Momand et al., 1992) . Phosphorylation of N-terminal peptides on serine 20 or threonine 18, which reside within the HDM binding region (residues 17 ± 27), but not serines 15, 33, or 37, reduces the anity of p53 for HDM BoÈ ttger et al., 1999; Unger et al., 1999; Kussie et al., 1996) . DNA damage induces the phosphorylation of serine 20 and threonine 18 in intact cells, suggesting that the phosphorylation of amino-terminal residues of p53 causes dissociation of HDM, accumulation of p53 and transactivation of target genes (Chehab et al., 1999; Shieh et al., 1999; Tibbets et al., 1999; Sakaguchi et al., 1998) .
Recent evidence has revealed that serine residues in the amino terminal region of p53 are phosphorylated sequentially following DNA damage. Serines 15 and 33 are phosphorylated within 1 h after exposure of cells to UV radiation, serine 37 phosphorylation is detected 2 ± 4 h after UV, and the phosphorylation of serine 20, not visible until 4 h after damage, continues to increase for up to 9 h (Bulavin et al., 1999; Shieh et al., 1999; Sakaguchi et al., 1998) . The time course of threonine 18 phosphorylation is not known. These relative timings are consistent with apparent requirements of one phosphorylation event for another. A serine 33-to-alanine mutant protein cannot be phosphorylated on serine 37 and shows reduced phosphorylation on serine 15 after UV damage (Bulavin et al., 1999) . Phosphorylation of serine 15 is required for phosphorylation of threonine 18 after ionizing radiation, as shown by analysis of the serine 15-to-alanine mutant protein . These studies indicate that phosphorylations that occur soon after DNA damage (i.e., at residues 15 and 33) begin a cascade that unmasks additional phosphorylation sites (i.e., at residues 18 and 37).
Despite the growing body of biochemical evidence that speci®c changes in p53 phosphorylation accompany DNA damage, studies of p53 mutant proteins that cannot be phosphorylated at speci®c residues have led some authors to conclude that amino-terminal phosphorylation has little or no eect on stabilizing the protein after damage (Ashcroft et al., 1999; Blattner et al., 1999) . To investigate this important issue further, we compared the eects of DNA damage on the accumulation and transactivation of wild-type, S15A, S37A, and S15/37A mutant p53 proteins expressed ectopically in human p53-null ®broblasts.
Results

Expression of wild-type and mutant p53 proteins
Wild-type, S15A, S37A and S15/37A p53 proteins were expressed stably in a p53-null, Li-Fraumeni-derived, ®broblast cell line. MDAH041 cells expressing wildtype p53 respond to DNA damage by transactivating downstream genes, leading to growth arrest (Agarwal et al., 1995) . Mutant and wild-type p53 cDNAs were introduced into MDAH041 cells under the control of a tetracycline-regulated promoter, so that the levels of p53 could be kept low during transfection, preventing p53-mediated growth arrest. Three independent clones stably expressing wild-type p53, ®ve expressing the S15A mutant, ®ve expressing the S37A mutant, and six expressing the S15/37A mutant (TRwt, TR15, TR37, and TR15/37, respectively) were studied. The basal level of p53 in each clone is regulated by tetracycline. However, even in the absence of tetracycline (maximal protein induction), cells expressing wild-type p53 continued to grow and incorporate BrdU, indicating that even the induced levels of p53 proteins do not trigger growth arrest (data not shown). The levels of wild-type and mutant p53 proteins in the absence of tetracycline are similar to the levels of endogenous p53 in normal diploid human ®broblasts. Therefore, experiments were carried out in the absence of tetracycline unless otherwise indicated.
The accumulation of wild-type p53 protein following DNA damage was compared in the TRwt clones and the normal diploid human ®broblasts cell strain WI-38, to assess the status of the signaling pathway to p53 in the MDAH041 cell background (Figure 1 ). Treatment with UV radiation or adriamycin, which induces double-strand breaks in DNA and generates freeradicals, caused wild-type p53 to accumulate in both WI-38 cells and the TRwt clones. In both, the levels of protein peaked 18 h after irradiation with UV. After treatment with adriamycin, p53 accumulated more quickly in WI-38 cells than in the TRwt clones. However, maximal protein levels were reached 24 h after treatment in both cells. Phosphorylation of serine 15 occurred in both WI38 and TRwt cells 18 h after treatment with UV or adriamycin ( Figure 1c and data not shown). Phosphorylation of serines 15 and 37 is required for p53 to accumulate after irradiation with UV Western analysis showed that the accumulation of the S15A, S37A, and S15/37A mutant proteins in response to UV radiation was impaired compared to that of the wild-type clone TRw2 (Figure 2a) . To quantify the dierence between the accumulation of wild-type and mutant proteins, the levels of p53 proteins were measured by Western analysis and chemi¯uorescence 18 h after irradiation with UV in all clones (Figure 2b ). For each clone, the mean percentage increase and the standard error was estimated as described in Materials and methods. The accumulation of p53 protein was defective in all mutant clones compared to the wildtype clones, although there was clonal variation. For example, in clones TR15-2 (225% increase), 37-1 (130% increase) and TR15/37-1 (290% increase) the accumulation of p53 was closer to that seen in wildtype clones (average 460% increase), whereas clones TR15-1 (3% increase), TR37-4 (50% increase), and TR15/37-2 (50% increase) accumulated little or no p53 protein following irradiation with UV. Analysis of variance for pairwise comparisons of each type of clone indicated that the accumulation of the S15A, S37A, and S15/37A mutant proteins was signi®cantly dierent from the wild-type (P values 0.001, 50.01, and 0.004, respectively; Figure 2c ). There was no dierence between the double mutant and either of the single mutants. Therefore, serines 15 and 37 both need to be phosphorylated for the p53 protein to accumulate eciently following UV damage.
UV and adriamycin signal to p53 through different pathways
To determine whether the requirement for the phosphorylation of residues 15 and 37 for accumulation of p53 protein is unique to the UV response, we analysed the ability of the wild-type and mutant protein to accumulate after adriamycin treatment. Adriamycin, which induces double-strand breaks in DNA and generates free radicals, is likely to stimulate dierent signals than UV radiation. The accumulation of S15A, S37A, and S15/37A mutant proteins was similar to that of the wild-type p53, while the S15/37A mutant protein accumulated slightly less ( Figure 3a ). The levels of mutant and wild-type p53 proteins were measured 18 h after adding adriamycin ( Figure 3b ). Analysis of variance for pairwise comparisons between clones types revealed no signi®cant dierence between wild-type and mutant clones (Figure 3c ). Therefore, the phosphorylation of neither serine 15 nor 37 is required for ecient accumulation of p53 after adriamycin treatment, suggesting that damage in¯icted by UV or adriamycin is transmitted to p53 through separate pathways.
Decreased basal association of the S15/37A mutant protein with HDM Several studies have suggested that the phosphorylation of N-terminal serines following DNA damage leads to disassociation of p53 from HDM. The failure of the serine S15A and S37A mutant proteins to accumulate following DNA damage led us to compare the ability of the wild-type and S15/37A double mutant proteins to bind to HDM before and after irradiation with UV. Western analyses of whole cell extracts revealed that untreated and UV-treated samples (4 h) had similar levels of wild-type and S15/37A mutant proteins (Figure 4) . The p53/HDM complex was immunoprecipitated from control and UV-irradiated cells with an antibody to HDM. Interestingly, in untreated cells, the mutant p53 protein complexed poorly with HDM compared to the wild-type. Both wild-type and mutant p53 proteins dissociated from HDM following UV treatment. These results suggest that mutation of serines 15 and 37 impairs the basal p53-HDM interaction, but not the dissociation of these two proteins after UV treatment. 
Serine 15 phosphorylation is necessary for basal p21 expression
Separate pathways lead to the accumulation of p53 protein and transactivation (Hupp et al, 1995; . Serines 15 and 37 lie within the transactivation domain of p53 and could contribute to transactivation in addition to accumulation. Untreated MDAH041 cells, and clones expressing the wild-type, S15A, S37A and S15/37A proteins, were analysed for basal levels of p53 protein and p53-responsive mRNAs (Figure 5a ). Although the levels of p53 protein in these clones were similar, all clones with a S15A mutation showed a marked defect in basal p21 expression. Clones 15-1, 15-2, 15/37-1 and 15/37-5 had basal levels of p53 protein close to those of the wildtype clones but p21 mRNA levels close to those of p53-null MDAH041 cells. Therefore, mutation of serine 15 to alanine impairs the ability of p53 to regulate basal expression of p21. However, when the S15A mutant protein is expressed at a higher level, for example, in clone 15/37-2, the p21 promoter can be driven. Western analyses using an antibody speci®c for phosphoserine 15 revealed basal phosphorylation of this residue in the wild-type and S37A, but S15A and S15/37A proteins ( Figure 5b and data not shown). In contrast to the results for p21, we observed little or no dierence between the basal levels of HDM and GADD45 mRNAs in MDAH041 cells, compared to clones expressing either wild-type or mutant p53 proteins. Thus, the basal expression of dierent target genes is dierentially regulated by p53.
The phosphorylation of serines 15 or 37 is not required for the increased expression of p21, GADD45, or HDM in response to irradiation with UV p53-responsive mRNAs were analysed 0, 6, 12, 18, and 24 h after the cells were irradiated. In all clones expressing p53, the levels of HDM, p21, and GADD45 mRNAs increased following damage ( Figure  6a ,b and data not shown). The percentage increase in responsive mRNAs corresponded to the levels of p53 protein accumulated, and p53-null MDAH041 cells had the lowest induction. Therefore, the serine-toalanine mutant proteins studied can transactivate downstream genes, although the increases are smaller than with wild-type p53, probably due to the accumulation of less protein after damage. The p53-dependent promoter activity observed in the 15/37 clones indicates that the mutant proteins are capable of driving transcription. However, since the levels of wild-type and mutant p53 proteins are dierent after UV irradiation, we cannot rule out the possibility that blockade of the ability to phosphorylate serines 15 or 37 has a subtle eect on the transactivation of downstream genes or more dramatic eects on other promoters not studied here.
Discussion
The p53 tumor suppressor responds to many types of DNA damage and adverse environmental conditions to drive cellular responses tailored to the speci®c inducer. For example, p53 promotes cell survival after UV damage by arresting the cell cycle reversibly, allowing time for DNA repair, or it promotes stable reversible arrest when starvation for nucleotides creates a risk of DNA damage, as when cells are treated with N-(phosphonacetyl)-L-aspartate (PALA), which starves them for pyrimidine nucleotides Linke et al., 1996; Smith et al., 1995; van Laar et al., 1994) . Conversely, p53 can promote cell death by inducing apoptosis or irreversible growth arrest after ionizing radiation has damaged DNA severely (Huang et al., 1996 ; DiLeonardo et al., 1994; Lowe et al., 1993; Livingstone et al., 1992; Yin et al., 1992) . The ability of p53 to discriminate between dierent adverse events indicates that multiple pathways to modulate the posttranslational modi®cation of p53 dierentially.
The patterns of p53 phosphorylation following DNA damage are complicated and therefore should be analysed in a system that preserves as much as possible the controls that regulate endogenous p53 protein in normal cells. To this end, we have expressed wild-type and phosphorylation-site mutant p53 proteins at normal basal levels in a p53-null ®broblast cell line that has many of the properties of normal ®broblasts , 1997) .
The in vivo eect of serine-to-alanine mutations at sites outside the p53-HDM interaction domain is unexpected. The phosphorylation of serine 15 is required for ecient phosphorylation of N-terminal peptides on threonine 18 . Threonine 18 resides in the region of p53 that binds to HDM, and phosphorylation of this site plays an important role in p53-HDM dissociation following DNA damage BoÈ ttger et al., 1999) . By mutating serine 15 we may have disrupted the pathway leading to threonine 18 phosphorylation. We did observe a little accumulation of the S15A mutant protein. It is possible that, although the phosphorylation of serine 15 may greatly enhance the phosphorylation of threonine 18, threonine 18 can be phosphorylated to a limited degree even in the absence of phosphorylation at serine 15.
A slightly dierent scenario can be imagined for the phosphorylation of serine 37. Although no other phosphorylation event has been shown to depend upon phosphorylation at this site, one study did show an increase in phosphorylation on serines 15, 18, and 20 when serine 37 was mutated to alanine . Although we observed no increase in the phosphorylation of serine 15 in the S37A mutants, we were unable to examine the phosphorylation of threonine 18 or serine 20. Enhanced phosphorylation at these sites could explain the observed decrease in basal p53-HDM binding. Phosphorylation at serine 37 in response to UV occurs earlier than at other sites (serine 20 or threonine 18, for example) and may change the N-terminal architecture to enhance the access of kinases. Other properties of serine 37, such as its phosphorylation following UV-induced DNA damage and in vitro phosphorylation of the orthologous mouse serine 34 by the UV-activated kinase JNK, help to substantiate the novel function for the phosphorylation of serine 37 that our work has uncovered, that this residue must be phosphorylated to ensure the proper accumulation of p53 protein following UV irradiation (Milne et al., 1995) .
Although serines 15 and 37 are both required for the p53 protein to accumulate after irradiation with UV, phosphorylation of either residue is sucient for the protein to accumulate in response to adriamycin. Therefore, our results add to the body of evidence indicating that several separate pathways signal to p53: UV, ionizing radiation and PALA all signal through distinct pathways (Maki and Howley, 1997; Chen et al., 1996; Hartley et al., 1995; Kanna et al., 1995; Lu and Lane, 1993) .
The reduced anity of the S15/37A double mutant protein for HDM in untreated cells indicates a possible explanation for why it accumulates so little following UV radiation. With less mutant p53 protein associated with HDM, the eect of dissociation after UV treatment is dampened, resulting in a lower percentage increase in p53 protein. It will be very interesting to determine how basal phosphorylation at other residues (threonine 18 and serine 20, for example) is aected by these mutations. It is not clear whether the accumulation of p53 protein following UV damage depends entirely on its binding to HDM. However, our results do demonstrate a critical role for the phosphorylation of serines 15 and 37 in regulating the binding of p53 HDM in unperturbed cells.
Several of our observations are aected by clonal variation. For example, TR15-2, TR37-1, and TR15/ 37-1 cells were impaired less dramatically after irradiation with UV than were other clones. Similarly, after adriamycin treatment the TR15/37-5 clone showed a nearly wild-type response. The phenotypic variability we observed may be due to variation in expression of exogenous p53 and to dierences in the inherent response to damage of particular clones. For example, there may be clonal dierences in the endogenous levels of endogenous proteins that can regulate the stability of p53, such as JNK1 or p300 (Fuchs et al., 1998a,b; Grossman et al., 1998) .
We analysed the eect of mutating serines 15 or 37 on the ability of p53 to support the basal and DNA damage-induced transcription of the HDM, p21, and GADD45 genes. Phosphorylation has been shown previously to stimulate the transactivation function of p53 . In clones carrying an S15A mutation, the basal levels of p21 were nearly equivalent to those of p53-null MDAH041 cells, whereas clones expressing the wild-type or S37A mutant proteins had much higher levels of p21 mRNA. However, clone 15/37-4, which expresses a higher basal level of p53 than do the wild-type clones, also showed an increase in basal expression of p21 compared to MDAH041 cells, suggesting that the phosphorylation of serine 15 is not absolutely required for p53 to increase p21 expression. The loss of basal p21 expression in S15A mutant clones may re¯ect a loss of basal p300 binding Lambert et al., 1998) . Interestingly, the basal activity of the HDM and GADD45 promoters was not aected dierentially by wild-type and phosphorylation mutant p53 proteins, indicating dierences in the regulation of these three promoters. Our ®ndings are consistent with the observation of others that the basal level of p21, but not HDM, is regulated by the basal level of p53 (Mendrysa and Perry, 2000; Tang et al., 1998; Agarwal et al., manuscript in preparation) . We observed little or no dierence in the accumulation of HDM, p21, and GADD45 mRNA following UV-induced damage to DNA among the wild-type and mutant clones. It is possible that the phosphorylation of other aminoterminal sites following DNA damage might relieve repression of the transactivation function of p53 by HDM even when serines 15 or 37 cannot be phosphorylated.
Using a p53-null cell line and an expression system that allows normal low basal expression of exogenous p53, we have found that phosphorylation of serines 15 and 37 of p53 are required for the protein to accumulate following UV damage. Most importantly, our work establishes a necessary role for p53 phosphorylation in order for the protein to accumulate and, in the case of serine 15, to maintain basal levels of p21. Previous work has failed to implicate any function for the phosphorylation of serine 37 (Ashcroft et al., 1999; Blattner et al., 1999) . In agreement with these workers, we do conclude that the phosphorylation of these residues is not the only mechanism that regulates the accumulation of p53 since a little accumulation was observed in S15/37A double mutant cells after irradiation with UV or treatment with adriamycin. Analysis of additional phosphorylation site mutants will help us to understand more completely the complex requirements for multiple phosphorylation events in p53-dependent signaling.
Materials and methods
Constructs pTO and pTA.hygro were previously reported (Gossen and Bujard, 1992) . The neomycin resistance gene was removed from pRSV.neo (Clontech) by digestion with NdeI and SmaI blunt-ended and cloned into the blunt pTO XhoI site. Wild-type p53 cDNA (1.8 kb), a gift from David Lane (University of Dundee, Scotland) was subcloned into pTO.neo and pBluescript by utilizing BamHI to create pTO.p53(1.8)neo and pBS.p53(1.8). The serine 37-toalanine mutant was generated by PCR SOEing (Horton et al., 1990) using pTO.p53.neo as template. The S15A mutation was created with the forward primer 5'-CGAGCCCCCTCTGGCTCAGGAAACATT-3' and the reverse primer 5'-AAATGTTTCCTGAGCCAGAGG-3' and the S37A mutation was created with the forward primer 5'-GTCCCCCTTGCCGGCCCAAGCAATGG-3' and the reverse primer 5' 5'-GCAAGGGGGACAGAACGTTG-3'. The forward mutagenic primers were paired with the reverse primer 5'-GGGGATCCGGGTGGGAGGCTGTCA-3' and the reverse mutagenic primers were paired with the forward primer 5'-TCCACGCTGTTTTGACCTCC-3' (both located in p53 UTR regions). The products from these reactions were gel puri®ed and used as templates for the SOEing reaction with the forward primer 5'-CCGAATTCCCGGGT-CACTGCCATGGAGG-3' and the reverse primer 5'-GGCTGGGGCGCGGAGCTGG-3' (both located in pTO). The products of the ®nal reaction were subcloned into the PCR cloning vector PCR II (Invitrogen) and sequenced. The S15/37A mutation was created by using the S15A primers on a S37A template. Constructs carrying the desired mutation were subcloned into pBS.p53wt(1.8) by exchange of the Nterminal NcoI fragment. p53 S37A cDNA was then transferred to pTO.neo via the BamHI sites. Constructs were sequenced in their entirety and tested for promoter activity by transient transfection.
Cell lines and culture conditions
Cells were grown in Dulbecco's minimal essential medium (Gibco), supplemented with antibiotics and 10% fetal bovine serum (Gibco) in a humidi®ed atmosphere containing 10% CO 2 . MDAH041, a spontaneously immortalized Li-Fraumeni skin ®broblast cell line, was described previously (Bischo et al., 1990) as were MDAH041 cells stably transfected with pTA (Agarwal et al., 1995) . The TRwt, TR15, TR37, and TR15/37 cell lines were generated by calcium-phosphate transfection of pTO.p53.neo constructs into MDAH041.p-TA(hygro) cells in the presence of tetracycline (1 mg/ml). Selection of stable clones was done with G418 (0.4 mg/ml active). Clones screened by Western transfer for p53 expression were prepared by ®rst removing tetracycline for 24 h, then treating the cells with adriamycin (200 ng/ml) for an additional 24 h to increase the levels of p53. Clones TRwt-3, TR37-3, TR37-4, TR15/37-1, and TR15/37-4 had more p53 protein than TRwt-2 and were therefore used in the presence of tetracycline (0.01 mg/ml) to normalize the basal p53 levels to that of TRwt-2 cells.
Western analyses
Western transfers onto polyvinylidene di¯uoride (PVDF) membranes (Millipore) were performed with whole-cell extracts after separation by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (10% acrylamide). Protein concentrations of lysates were determined by the Bradford method (Biorad) and equal quantities of protein were loaded for each sample. To detect p53, the cells were lysed in 20 mM Tris hydrochloride, pH 7.4, 1% NP40, 150 mM NaCl, 5 mM EDTA, 1 mM phenylmethane sulfonyl¯uoride, 10 mg/ml aprotinin, 25 mg/ml leupeptin and 1 mg/ml pepstatin A. The membranes were probed with the DO-1 monoclonal antibody to p53 (Santa Cruz), which was detected with a goat antimouse antibody conjugated to horseradish peroxidase (BioRad), using enhanced chemiluminescence (Dupont). To quantify the levels of p53, the membranes were analysed by using enhanced chemi¯uorescence (Dupont) and read using a StormImager (Molecular Dynamics). The results were analysed with ImageQuant software. Serine 15 phosphorylation was detected using phospho-p53 (Ser 15) antibody (New England Biolabs).
Immunoprecipitations p53-HDM complexes were immunoprecipitated with the HDM antibody SMP-14 (Pharmingen) according to Picksley et al. (1994) except that 0.5% NP40 was used. Brie¯y, the cells were lysed for 20 min on ice and the lysates was cleared by centrifugation for 15 min at 12 0006g. SMP-14 antibody (2 mg) was added to 10 mg of total lysate and rocked at 48C for 1.5 h. Antibody complexes were captured on GammaBind G Sepharose (Amersham Pharmacia), rocking at 48C for 1 h. The Sepharose-bound complex was washed four times in cold lysis buer and the proteins were denatured in 26SDS ± PAGE loading buer (100 mM Tris hydrochloride, pH 6.8, 4% SDS, 0.2% bromophenol blue, 20% glycerol, 1.3 M bmercaptoethanol and separated by SDS-polyacrylamide gel electrophoresis (10% acrylamide). Transfer to PVDF membranes was as described above. After transfer, the membranes were cut to separate p53 from HDM. p53 was detected by using p53-HRP (Santa Cruz) and HDM was detected with 2A10 (Chen et al., 1993) .
Northern analyses
Total RNA was extracted with the Trizol reagent (Gibco/ BRL), separated by electrophoresis in a denaturing agarose gel, transferred to Hybond-N + nylon membranes (Amersham) by capillary action and probed with 32 P-labeled probes for HDM, p21, GADD45 or GAPDH. Quantitation was performed by using a PhosphorImager (Molecular Dynamics) and the results were analysed with ImageQuant software.
Irradiation with UV and treatment with adriamycin
All treatments were performed 24 h after removal of tetracycline. The UV dose in all cases was 25 J/m 2 , measured by using a Traceable Ultra Violet Light Meter (Control Company). UV irradiation was performed after removal of most of the culture medium. Adriamycin was used at 200 ng/ ml throughout.
Statistical analysis
An estimate of the mean for each individual clone was calculated as Best Linear Unbiased Estimates, where individual clones were considered to be random eects and each mean was regressed toward the overall mean for each clone type (Robinson, 1991) . The overall mean for each type of clone was estimated as a least squares mean, with individual clones considered to be random eects. Calculated P-values among clone types were adjusted for multiple comparisons using the Tukey-Kramer method in order to maintain an overall 0.05 signi®cance level for each hypothesis (Kramer, 1956) . Standard errors for each clone type and individual clone were calculated as the square root of the variance of the mean, which was a function of the withinclone and between-clone variability. Analyses were done using the Mixed Procedure (SAS Statistical Software).
